Ft News

The discovery of a new antibiotic has brought fresh hope that a looming health crisis caused by drug resistant infections can be avoided. Called teixobactin, it is the result of a private public collaboration involving universities in the US and Germany, and the US biotech company NovoBiotic pharmaceuticals. Andrew Ward, pharmaceuticals correspondent, talks to Clive Cookson, science editor, about the discovery.  See acast.com/privacy for privacy and opt-out information.